Inhibition of TGF-β signaling with SB505124 significantly abrogated the TGF-β induced expression of LINC01518 in HNSCC cells (~ 80% and ~ 50% reduction in SCC-25 and FaDu cells, respectively) (Fig. 1E). Here, TGFB1 is linked to head and neck squamous cell carcinoma.